Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of ...

Argus Research analyst David Toung maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday. The company’s shares ...

Citi analyst Joanne Wuensch reiterated a Buy rating on Intuitive Surgical (ISRG – Research Report) yesterday and set a price target of $711.00.

Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.